Fola Community Action Layout

specializing in addiction recovery

CALL TODAY

8014-8018 South Ashland Avenue Chicago, IL 60620

773.487.4316

FCASINC@YAHOO.COM

The intake process was quick profrestional and prompt. the staff is caring and understanding of each and every clients personal needs and is eager and willing to help in any way possible.for such a large case load i comend the entire staff for there organization. Upper management are personable and easy to get along with,and for the staff that show up at the break of dawn along with us,well lets just say your contribution to the whole process is without equal. You all steer the ship and we’d all sink without you. Thank You Fola and continue being that beacon of hope. TJH

You’ve wanted a better life for a long time now. You’ve felt powerless to change but there seems to be a small sense of hope. Call one of our understanding and compassionate advisers right now. We understand what you are going through. 773.487.4316

Services Provided

Substance Abuse Treatment Services • Detoxification • Methadone maintenance • Methadone detoxification • Buprenorphine and suboxone treatment services AddictionTreatment Programs Available • Addiction treatment for persons with HIV/AIDS • Addiction treatment for gays and lesbians • Addiction treatment for seniors/older adults • Addiction treatment for pregnant/postpartum women • Addiction treatment for women • Addiction treatment for men • Court ordered addiction treatment

Types Of Addiction Treatment Care • Outpatient counseling treatment

• Holistic rehabilitation treatment, alternative treatment

Payment And Payment Assistance • Self payment (cash, credit card, check, money order) • Medicaid • Income-based sliding fee scale (Fee is based on income and other factors) • Loans and financing (Check with facility for details)

While in REBUILDING

YOUR RELATIONSHIP

from Recovery

Addiction

8014-8018 South Ashland Avenue • Chicago, IL 60620 | PH: (773)487-4316

One in three older Americans with Medicare drug coverage is prescribed opioid painkillers, but for those who develop a dangerous addiction there is one treatment Medicare won’t cover: METHADONE. Methadone is the oldest, and experts say, the most effective of the three approved medications used to treat opioid addiction. It eases cravings without an intense high, allowing patients to work with counselors to rebuild their lives. Federal money is flowing to states to open new methadone clinics through the 21st Century Cures Act, but despite the nation’s deepening opioid crisis, the Medicare drug program for the elderly covers methadone only when prescribed for pain. Methadone doesn’t meet the requirement of Medicare’s Part D drug program because it can’t be dispensed in a retail pharmacy. Instead, in the highly regulated methadone system, patients first are assessed by a doctor, then show up daily at federally certified methadone clinics to take their doses of the pink liquid. Or, like Purvis in Maryland, they prove through repeated urine screens that they have earned the right to weekly take-home doses. An estimated 300,000 Medicare patients have been diagnosed with opioid addiction, and health officials estimate nearly 90,000 are at high risk for opioid misuse or overdose. Buprenorphine, a more expensive and slightly less regulated treatment drug, is covered by Medicare but few doctors who accept new Medicare patients have obtained federal waivers to prescribe it. A recent study of Medicare claims found prescriptions for buprenorphine for only 81,000 patients.

More evidence that the crisis affects seniors: Opioid overdoses killed 1,354 Americans ages 65 and older in 2016, about 3 percent of the 42,000 opioid overdoses that year. older patients in treatment if they’ve had commercial insurance that covered their care before turning 65, said counselor Angela Caldwell of Montgomery Recovery Services in Rockville, Maryland. A national organization for methadone clinics says the clinics now have 25,000 Medicare beneficiaries who are either paying out of pocket (about $80 per week) or getting care through state-run Medicaid or block grant programs. Medicare’s policy means clinics often scramble to keep

Methadone is the oldest, and experts say, the most effective of the three approved medications used to treat opioid addiction.

Stay beautiful

Don’t do drugs

(773)487-4316

Feeling STRANDED?

Don’t face opioid addiction alone. Get help today. (773)487-4316

Methadone Treatment Program Success Rate

There is significant amount of money used for the addiction treatment methods that do not work. This is why it is vital to identify the success rates of treatment programs so that cost-effective methods can be implemented. In 2008 it was estimated that the economic burden that mental illness imposes on Canada is around $51 billion a year. This amount covers the costs for healthcare, lost productivity, and the reduction in the quality of life. Let’s take a look at the methadone treatment program success rate to see if it is truly worth the cost.

Long-Term Abstinence The use of the methadone treatment program for addiction was initially researched during the early 1960s. In the 40 years that followed, it has evolved to become the most recognized standard of care for opiate addiction. The detoxification and drug-free techniques can be very appealing in terms of the need to find a recovery solution that does not involve any medication. However, it only yields a 5% to 10% success rate. Compare this to the 60% to 90% methadone treatment program success rate and you would understand why it has become an international standard. The longer that people stay on this program, the more they improve their chances of achieving long-term abstinence.

Success Rates The clinical data available can demonstrate that a biochemical treatment of addiction will deliver 75% to 80% recovery rate within a span of 5 years. Compare this to the traditional 12-step or strictly counseling approach that does not use biochemical treatment and you get a substantially lower recovery rate of 15% to 25% in 5 years. After over 50 years more than 95% of the treatment programs in the U.S. and Canada still use the 12-step program. This does not resolve the physiological damage that has resulted from the substance abuse. It is necessary to recognize this problem to achieve cellular rebalancing and recovery from addiction.

In a study of California heroin addicts that involved 600 participants originally, about half are now dead. Only 10% of them have successfully established long-term stable abstinence. Many have not been exposed to methadone maintenance, which could have helped them reach a rehabilitated state.

IT IS NECESSARY TO RECOGNIZE THIS PROBLEM TO ACHIEVE CELLULAR REBALANCING AND RECOVERY FROM ADDICTION.

ADDICT

1 out of every 5 teens has used prescription drugs to get high.

Teens are more likely to use prescription drugs than any other illicit drugs, besides marijuana.

8014-8018 South Ashland Avenue Chicago, IL 60620

(773)487-4316

THEY ARE MORE THAN YOU THINK LIKE YOU

80 percent of the babies born to heroin-addicted mothers are born addicts. Like mommy, like baby. (773)487-4316

The risk for drug overdose is 12.7 times greater in individuals who have been incarcerated than in individuals in the general population. An article published in the Journal of Law, Medicine, and Ethics described the consequences of limited treatment options for individuals with opioid use disorder in the criminal justice system. Curtis Bone, MD, MHS, from the Yale University School of Medicine, and colleagues recalled a patient who refused treatment with methadone for opioid use disorder because he worried about withdrawal: although heroin withdrawal effects are significant, the patient worried more for the prolonged effects of methadone withdrawal, particularly in a prison environment. After this patient encounter, Dr Bone explored the reasons behind prison refusal to accommodate methadone, recognizing also that the criminalization of drugs across the United States has led many with substance use disorders to regard “incarceration...[as] a foregone conclusion.” Among those treated with methadone or buprenorphine, 70% return to employment or schooling, and risk for overdose and viral illnesses are significantly reduced. Despite these positive effects, just 55% of federal prison medical directors report offering methadone, and even fewer offer buprenorphine. Among prisons that do supply addiction treatment, the outcomes include reduced rates of mortality, hepatitis C infection, and re- incarceration. Dr Bone also noted that methadone treatment “returns 12-14 dollars for every dollar spent,” a significant financial incentive for its use. Even so, prisons largely do not adopt methadone treatment programs, often citing “staff objections.” Many prison staff members report not endorsing methadone because they perceive it as substituting 1 drug for another, or as a facilitator to addiction.5 However, scientific evidence and bioethics alike renounce these perceptions as unproductive and inaccurate.

Failure to treat addiction is detrimental both to incarcerated individuals themselves and to their communities, Dr Bone noted. The effect of addiction is disproportionately shouldered by low-income communities and communities of color. Children of parents with a substance abuse disorder have higher rates of emotional and behavioral problems than the general population. In addition, communities among which rates of addiction and incarceration are high have increased risk for HIV and hepatitis. diseases may be a byproduct of the federal prison system’s failure to address substance abuse among the incarcerated. In addition to systematic refusal to accommodate methadone programs, patients themselves often reject the option because they fear the “horrific” Dr Bone postulates that the heightened risk for these

experience of methadone withdrawal in prison, as Dr Bone’s once did.

(773)487-4316

OPIOID ADDICTION: “LET’S TALK ABOUT IT.” Learn how faith communities can extend COMPASSION & SUPPORT

to people in recovery and to their families

What is Addiction?​ According to the American Society of Addiction Medicine, addiction is defined as “Addiction is a primary, chronic disease of brain reward, motivation, memory and related circuitry. Dysfunction in these circuits leads to characteristic biological, psychological, social and spiritual manifestations. This is reflected in the individual pursuing reward and/or relief by substance use and other behaviors. The addiction is characterized by impairment in behavioral control, craving, inability to consistently abstain, and diminished recognition of significant problems with one’s behaviors and interpersonal relationships. Like other chronic diseases, addiction can involve cycles of relapse and remission. Without treatment or engagement in recovery activities, addiction is progressive and can result in disability or premature death.” ​Treatment For Addiction ​While there are many types of addiction, TANG specializes in treating addiction to opiates and opioids. Our facilities institute treatment for opioid dependency through Methadone Detoxification, Methadone Maintenance, and counseling.

​Opioids are among the most abused substances. Opioids affect the brain receptors that govern the release of neurotransmitters (e.g., dopamine), which in turn regulate emotions and allow an individual to cope with physical pain.

Both are dangerous.

FOCUS ON Life 8014-8018 South ashland avenue • chicago, il 60620 call: (773)487-4316

(773)487-4316

SAY NO

not just a bad habit It’s NOT JUSTA BAD HABIT

Recent research and dialogue in the political sphere have brought long-simmering questions about addiction to the forefront: Is addiction truly a disease? Do addicts deserve to be treated like people who have a Recent res arch and ialogue in the political spher have brought long-sim ering questions about ad iction to the fore: Is addiction truly a disease? Do addicts deserve to b tr ated like people who hav a dise s that’s outside their control? disease that’s outside their control? While most researchers agree with the so-called disease model of addiction, stereotypes and cultural bias continue to stigmatize those with addiction because they made an initial choice to consume substances. However, Columbia University researchers point out that “choice does not determine whether 34 While most res archers agre with the so-called isease model of ad iction, ster otypes and cultural bias continue to stigmatize those with ad iction because they made an initial choice to consume substances. However, Columbia University res archers point out that “choice does not det rmine whether

something is a disease. Heart disease, diabetes and some forms of cancer involve personal choices like diet, exercise, sun exposure, etc. A disease is what happens in the body as a result of those choices.” Experts say that applying the distinction of choice to addiction creates biases that justify inadequate treatment. It begs the question New Jersey Gov. Chris Christie asked during a 2015 town hall meeting in New Hampshire. When Christie’s mother was diagnosed something is a disease. Heart disease, diabet s and some forms of cancer involve personal choices like diet, exercise, sun exposure, etc. A disease is what hap ens in the body as a result of those choices.” Experts ay that ap lying the distinction of choice to ad iction creates biases that justify inadequate treatment. It begs the question New Jersey Gov. Chris Christie asked uring a 2015 town hall me ting in New Hampshire. When Christie’s mother was diagnosed with lung cancer at 71 as a result of addiction to tobacco, he noted that with lung cancer at 71 as a result of ad iction to tobacco, he noted that

no one suggested that she should not be treated because she was “getting what she deserved,” he said. “Yet somehow, if it’s heroin or cocaine or alcohol, we say, ‘Ahh, they decided that, they’re getting what they deserve,’” Christie remarked. HOW ADDICTION WORKS After satisfying basic human needs like food, water, sleep and safety, people feel pleasure. That pleasure is brought by chemical releases in the brain. This is according to Columbia researchers, who note that the disease of addiction causes the brain to release high levels of those pleasure chemicals. Over time, brain functions of reward, motivation and memory are altered. After these brain systems are compromised, those with addiction can experience intense cravings for substance use, even in the face of harmful consequences. These changes can stay in the brain long after substance use desists. The changes may leave those struggling with addiction to be vulnerable to “physical and environmental cues they associate with substance use, also known as triggers, which can increase their risk of relapse,” write Columbia researchers.

not just a bad habit treatment and continued monitoring and support or recovery.

THE COLUMBIA RESEARCHERS DO HAVE SOME GOOD NEWS: Even the most severe, chronic form of the disorder can be manageable and reversible, usually with long term

35

You are not ALONE anymore.

Call one of our understanding and compassionate advisers right now. We understand what you are going through.

Fola Community Action 773.487.4316

I N AN EFFORT to encourage new treatments for opioid addiction, the Food and Drug Administration plans to begin permitting pharmaceutical companies to sell medications that help temper cravings, even if they don’t fully stop addiction. The change is part of a wider effort to expand access to so-called medication-assisted treatment, or MAT. The agency will issue draft guidelines in the next few weeks. A senior agency official provided details of the proposal to The New York Times. the agency said it would soon publish two guidances, recommendations for drugmakers, on the issue.

The new approach was signaled Saturday by the health and human services secretary, Alex M. Azar II, in remarks to the National Governors Association. Mr. Azar said the agency intended “to correct a misconception that patients must achieve total abstinence in order for MAT to be considered effective.” While the Trump administration has generally supported medication-assisted treatment, Mr. Azar’s predecessor, Tom Price, was not completely on board with it. Mr. Price caused an uproar among treatment experts when he dismissed some medications that reduce cravings through synthetic opioids last spring as substituting one opioid for another. He subsequently walked back those comments, saying officials should be open to a broad range of treatment options. Mr. Azar, who took office late last month, said he would work to reduce the stigma associated with addiction and addiction therapy, and would not treat it as a moral failing. The opioid epidemic is considered the most unrelenting drug crisis in United States history. In 2016, roughly 64,000 people were killed by drug overdoses, including from prescription opioid painkillers and heroin. to correct a misconception that patients must achieve total abstinence in order for MAT to be considered effective. Noting federal data showing that only one-third of specialty substance abuse treatment programs offer medication-assisted treatment, Mr. Azar said, “We want to raise that number — in fact, it will be nigh impossible to turn the tide on this epidemic without doing so.” Mr. Azar’s comments echo those of the F.D.A. chief, Dr. Scott Gottlieb, who has made battling opioid abuse a priority for his agency. Dr. Gottlieb has moved to reduce opioid prescriptions by doctors and dentists and to promote more medication- assisted treatment, defined as drugs used to stabilize brain chemistry, reduce or block the euphoric effects of opioids, relieve physiological cravings, and normalize body functions. The F.D.A. has approved three drugs for opioid treatment — buprenorphine (often known by the brand name Suboxone), methadone and naltrexone (known by the brand name Vivitrol) — and says they are safe and effective combined with counseling and other support. But the agency said it would soon publish two guidances, recommendations for drugmakers, on the issue.

Fola community action services inc. 8014-8018 South Ashland Avenue Chicago, IL 60620 773-487-4316

Believe you can and you’re halfway there.

Bring your self to life.

It’s time to discover a new form of yourself a new

path for yourself one that reaches well past the

impulse of the moment. It’s time to wake up in a

world of self-made character of self-determination.

8014-8018 South Ashland Avenue Chicago, IL 60620 773.487.4316 • FCASINC@YAHOO.COM

Page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 Page 10 Page 11 Page 12 Page 13 Page 14 Page 15 Page 16 Page 17 Page 18 Page 19 Page 20 Page 21 Page 22 Page 23 Page 24 Page 25 Page 26 Page 27 Page 28 Page 29 Page 30 Page 31 Page 32

Powered by